The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer.

There has been considerable interest in understanding the epitopes that bind the lectin Helix pomatia agglutinin (HPA) in breast cancer as the lectin has been shown to identify glycosylation changes associated with the development of metastatic disease. HPA has previously been shown to recognize aberrant O-linked α-N-acetylgalactosamine (GalNAcα)/mucin glycosylation in cancer, including exposed Tn epitopes. However, recent glycan-array analysis reported that diverse epitopes are also recognized by the lectin, e.g. consortium for functional glycomics (CFG) data: GalNAcα1,3Gal; β-GalNAc; GlcNAcβ1,4Gal. The intriguing observations from the CFG array led to this study, in which HPA-binding epitopes were localized and characterized in an in vitro model of breast cancer metastasis. HMT3522 (benign disease), BT474 (primary cancer) and T47D/MCF7 (metastatic cancer) cells were assessed in confocal microscopy-based co-localization studies and a glycoproteomic analysis based on 2-dimensional electrophoresis (2DE), western blotting and mass spectrometry was adopted. HPA binding correlated with levels of integrin α6, transcription factors heterogeneous nuclear ribonuclear protein (HnRNP) H1, HnRNP D-like, HnRNP A2/B1 as well as heat shock protein 27 (Hsp27), glial fibrillary acidic protein and enolase 1 (ENO1). These glycoproteins were non-detectable in the non-metastatic breast cancer cell lines. The recognition of HnRNPs, Hsp27 and ENO1 by HPA correlated with O-GlcNAcylation of these proteins. Integrin α6 was the most abundant HPA glycoprotein in the breast cancer cells with a metastatic phenotype; this concurred with previous findings in colorectal cancer. This is the first report in which HPA has been shown to bind O-GlcNAcylated transcription factors. This class of proteins represents a new means by which HPA differentiates cancer cells with an aggressive metastatic phenotype.

[1]  J. Chiésa,et al.  Increased prosomal proteins in breast cancer cells and in neighboring normal cells in Parsi and non-Parsi populations , 2012, Journal of Cancer Research and Clinical Oncology.

[2]  D. Mahvi,et al.  Lack of association between tumor necrosis and hsp‐27 expression in primary breast cancer , 1996, Journal of surgical oncology.

[3]  U. Schumacher,et al.  Ulex europeus agglutinin-I binding as a potential prognostic marker in ovarian cancer. , 2007, Anticancer Research.

[4]  M. Gleave,et al.  Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E , 2010, Oncogene.

[5]  U Schumacher,et al.  Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma , 1994, Cancer.

[6]  G. Naumov,et al.  Solitary cancer cells as a possible source of tumour dormancy? , 2001, Seminars in cancer biology.

[7]  V. Piller,et al.  Comparison of the carbohydrate-binding specificities of seven N-acetyl-D-galactosamine-recognizing lectins. , 1990, European journal of biochemistry.

[8]  T. Wong,et al.  ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. , 2010, European journal of cancer.

[9]  D. Anderson,et al.  Blood type A and familial breast cancer , 1984, Cancer.

[10]  Anne Imberty,et al.  Biochemical and Structural Analysis of Helix pomatia Agglutinin , 2006, Journal of Biological Chemistry.

[11]  P. Levine,et al.  Epidemiologic features of rapidly progressing breast cancer in Tunisia , 1980, Cancer.

[12]  G. Hart,et al.  A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. , 2008, Molecular biology of the cell.

[13]  G. Curley,et al.  Identification, Cloning, and Characterization of Two N-Acetylgalactosamine-binding Lectins from the Albumen Gland of Helix pomatia , 2011, The Journal of Biological Chemistry.

[14]  U. Schumacher,et al.  E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung , 2009, British Journal of Cancer.

[15]  A. Leathem,et al.  PREDICTIVE VALUE OF LECTIN BINDING ON BREAST-CANCER RECURRENCE AND SURVIVAL , 1987, The Lancet.

[16]  Udo Schumacher,et al.  Lectin histochemical HPA-binding pattern of human breast and colon cancers is associated with metastases formation in severe combined immunodeficient mice , 1997, The Histochemical Journal.

[17]  R. Gebhardt,et al.  Overexpression of glutamine synthetase in human primary liver cancer. , 1994, Gastroenterology.

[18]  R. Weston,et al.  PATHOGENESIS OF COALMINER'S PNEUMOCONIOSIS. , 1965, Lancet.

[19]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[20]  M. Dwek,et al.  Proteome analysis of metastatic colorectal cancer cells recognized by the lectin Helix pomatia agglutinin (HPA) , 2007, Proteomics.

[21]  I. Virtanen,et al.  Binding of the blood group‐reactive lectins to human adult kidney specimens , 1990, The Anatomical record.

[22]  S. Brooks.  The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. , 2000, Histology and histopathology.

[23]  M. Teh,et al.  Proteomic characterization of differentially expressed proteins in breast cancer: Expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER‐2/neu status , 2008, Proteomics. Clinical applications.

[24]  M. Dwek,et al.  Helix pomatia agglutinin lectin‐binding oligosaccharides of aggressive breast cancer , 2001, International journal of cancer.

[25]  A. Imberty,et al.  Structural basis for recognition of breast and colon cancer epitopes Tn antigen and Forssman disaccharide by Helix pomatia lectin. , 2007, Glycobiology.

[26]  P. Højrup,et al.  Rapid identification of proteins by peptide-mass fingerprinting , 1993, Current Biology.

[27]  F. Herz,et al.  Expression of stress-response (heat-shock) protein 27 in human brain tumors: an immunohistochemical study , 2004, Acta Neuropathologica.

[28]  M. Tockman,et al.  Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. , 2001, Lung cancer.

[29]  Robert Camp,et al.  β1,6-Branched Oligosaccharides Are Increased in Lymph Node Metastases and Predict Poor Outcome in Breast Carcinoma , 2005, Clinical Cancer Research.

[30]  Y. Kakeji,et al.  Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma , 1991 .

[31]  A. Leathem,et al.  Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour , 1991, The Lancet.

[32]  Yoshinao Takano,et al.  Lymph Node Metastasis-Related Carbohydrate Epitopes of Gastric Cancer with Submucosal Invasion , 2000, Surgery Today.

[33]  R. Pagano,et al.  Molecular trapping of a fluorescent ceramide analogue at the Golgi apparatus of fixed cells: interaction with endogenous lipids provides a trans-Golgi marker for both light and electron microscopy , 1989, The Journal of cell biology.

[34]  J. Hampe,et al.  Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2) , 2009, Oncogene.

[35]  G. Hart,et al.  O-GlcNAc signaling: a metabolic link between diabetes and cancer? , 2010, Trends in biochemical sciences.

[36]  Masatoshi Watanabe,et al.  Malignant myoepithelioma of the breast metastasizing to the jaw , 1999, Virchows Archiv.

[37]  G. Naumov,et al.  Critical steps in hematogenous metastasis: an overview. , 2001, Surgical oncology clinics of North America.

[38]  J. Roth.  Cytochemical localization of terminal N-acetyl-D-galactosamine residues in cellular compartments of intestinal goblet cells: implications for the topology of O-glycosylation , 1984, The Journal of cell biology.

[39]  G. Hart,et al.  Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. , 2008, American journal of physiology. Endocrinology and metabolism.

[40]  M. Tempero,et al.  Purification and analysis of glycoproteins bearing blood group-A determinants from hamster pancreatic ductal adenocarcinomas. , 1992, Carcinogenesis.

[41]  A. M. Wu,et al.  Coding and classification of d-galactose, N-acetyl-d-galactosamine, and β-d-Galp-[1→3(4)]-β-d-GlcpNAc, specificities of applied lectins , 1991 .

[42]  G. Hart,et al.  N‐Propanoylmannosamine interferes with O‐GlcNAc modification of the tyrosine 3‐monooxygenase and stimulates dopamine secretion , 2008, Journal of neuroscience research.

[43]  S. Baldus,et al.  Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia. , 2000, Advances in cancer research.

[44]  B. Zetter,et al.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis. , 1990, Biochimica et biophysica acta.

[45]  S. Brooks,et al.  GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane , 2001, British Journal of Cancer.

[46]  E. Kabat,et al.  Immunochemical studies on the combining sites of Forssman hapten reactive hemagglutinins from Dolichos biflorus, Helix pomatia, and Wistaria floribunda. , 1983, Biochemistry.

[47]  G. Springer.  Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. , 1989, Molecular immunology.

[48]  G I Murray,et al.  Characterization and over‐expression of chaperonin t‐complex proteins in colorectal cancer , 2006, The Journal of pathology.